These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12043843)

  • 1. Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms.
    Gil-ad I; Shtaif B; Shiloh R; Weizman A
    Cell Mol Neurobiol; 2001 Dec; 21(6):705-16. PubMed ID: 12043843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells.
    Gassó P; Mas S; Molina O; Bernardo M; Lafuente A; Parellada E
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):71-7. PubMed ID: 21878360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.
    Marchese G; Casu MA; Bartholini F; Ruiu S; Saba P; Gessa GL; Pani L
    Eur J Neurosci; 2002 Apr; 15(7):1187-96. PubMed ID: 11982629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
    Bruggeman R; Westerink BH; Timmerman W
    Eur J Pharmacol; 1997 Apr; 324(1):49-56. PubMed ID: 9137912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
    Bishnoi M; Kumar A; Chopra K; Kulkarni SK
    Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential nigral expression of Bcl-2 protein family in chronically haloperidol and clozapine-treated rats: role in neurotoxicity and stereotyped behavior.
    Saldaña M; Bonastre M; Aguilar E; Marin C
    Exp Neurol; 2007 Feb; 203(2):302-8. PubMed ID: 17069804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.
    Chouinard G; Vainer JL; Bélanger MC; Turnier L; Beaudry P; Roy JY; Miller R
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov; 18(7):1129-41. PubMed ID: 7531355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol.
    Ukai W; Ozawa H; Tateno M; Hashimoto E; Saito T
    J Neural Transm (Vienna); 2004 Jun; 111(6):667-81. PubMed ID: 15168214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro.
    Heiser P; Enning F; Krieg JC; Vedder H
    J Psychopharmacol; 2007 Nov; 21(8):851-6. PubMed ID: 17881431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapyramidal syndromes in nonhuman primates: typical and atypical neuroleptics.
    Casey DE
    Psychopharmacol Bull; 1991; 27(1):47-50. PubMed ID: 1677773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.
    Farde L; Nordström AL; Wiesel FA; Pauli S; Halldin C; Sedvall G
    Arch Gen Psychiatry; 1992 Jul; 49(7):538-44. PubMed ID: 1352677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol-induced neurotoxicity--possible implications for tardive dyskinesia.
    Galili R; Mosberg ; Gil-Ad I; Weizman A; Melamed E; Offen D
    J Neural Transm (Vienna); 2000; 107(4):479-90. PubMed ID: 11215758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects.
    Peacock L; Solgaard T; Lublin H; Gerlach J
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):188-96. PubMed ID: 8935815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.